NRAS and neoplasm: This is the first study to date to characterize, in depth and in such a large clinically well‐defined cohort, genome‐wide CNAs, their differential frequencies, and relationship to clinico‐histomorphological tumor features, BRAF/NRAS mutation, and clinical outcomes using high‐resolution SNP array genotyping technology.